Despite the availability of thrombolytic and endovascular therapy for acute ischemic stroke,
many patients are ineligible due to delayed hospital arrival. The identification of factors …

Background: There is a pressing need to contribute evidence to the improvement in the early
identification of signs and symptoms associated with strokes, and address the treatment …

Background: Spanish is the second most-spoken language in the world. Spanish-speaking
populations (SSP) have heterogeneous cultural backgrounds, racial and ethnical origins …

Background Despite recent advances in acute stroke care, reperfusion therapies are given
to only 1%-8% of patients. Previous studies have focused on prehospital or decision delay …

Background: Despite recent advances in acute stroke care, only 1–8% of patients can
receive reperfusion therapies, mainly because of prehospital delay (PHD). Objective: This …

Background Previous studies have identified insufficient knowledge of stroke symptoms and
risk factors both among survivors of stroke and in the general population. The purpose of this …

Timely thrombolytic treatment is paramount after acute ischemic stroke (AIS); however, a
large proportion of patients experience substantial delays in presentation to hospital. This …

Background: Stroke is a leading cause of death and disability. Tissue plasminogen activator
(tPA) improves the clinical outcome when administered properly; however, the most …

Background and Purpose: Prehospital delay is the major factor limiting intravenous
thrombolysis and mechanical thrombectomy in acute ischemic stroke (AIS). This study aimed …

Prehospital delay after stroke symptom onset is a primary barrier to eligibility for reperfusion
therapies. Decision delay is an understudied contributor to prehospital delay. We aimed to …